1. In order to study the relationship between extracellular and intracellular concentrations of orthophosphate (Pi), phosphorus nuclear magnetic resonance spectra were recorded, at rest, from the flexor digitorum superficialis muscle of hypophosphataemic patients with vitamin D-resistant rickets, and patients with Paget's disease of bone before and after they had been made hyperphosphataemic by treatment with the drug ethylidene-l-hydroxy-l ,lbisphosphonate. Changes in intramuscular Pi were estimated from the ratio of the areas of the Pi to adenosine 5'-triphosphate peaks. Even though the plasma Pi concentration in these patients spanned a fourfold range (0.5-2.0 mmol/l) the corresponding intramuscular Pi concentration increased by only 2. A similar effect was observed in erythrocytes, from patients with these disorders, which were incubated in autologous plasma at 3 7 T , under an atmosphere of 0, + CO, (95 :5, v/v). However, chloride ions, which are transported passively across the cell membrane, showed no change in distribution between cells and plasma, indicating that there was no general effect on passive anion distribution.
1. In order to study the relationship between extracellular and intracellular concentrations of orthophosphate (Pi), phosphorus nuclear magnetic resonance spectra were recorded, at rest, from the flexor digitorum superficialis muscle of hypophosphataemic patients with vitamin D-resistant rickets, and patients with Paget's disease of bone before and after they had been made hyperphosphataemic by treatment with the drug ethylidene-l-hydroxy-l ,lbisphosphonate. Changes in intramuscular Pi were estimated from the ratio of the areas of the Pi to adenosine 5'-triphosphate peaks. Even though the plasma Pi concentration in these patients spanned a fourfold range (0.5-2.0 mmol/l) the corresponding intramuscular Pi concentration increased by only 2. A similar effect was observed in erythrocytes, from patients with these disorders, which were incubated in autologous plasma at 3 7 T , under an atmosphere of 0, + CO, (95 :5, v/v). However, chloride ions, which are transported passively across the cell membrane, showed no change in distribution between cells and plasma, indicating that there was no general effect on passive anion distribution.
3. When erythrocytes from normal subjects were incubated in autologous plasma (1.0 mmol of PJl) and in plasma supplemented with Pi (2.3 mmol of Pi/l), the Pi concentration in the cells, at steady state, increased only from 0.57 to 0.78 mmol/l cells, suggesting that the effect was not an artifact of disease or drug therapy.
Introduction
While it is widely recognized that severe hypophosphataemia [l, 21 or hyperphosphataemia [3] can lead to serious pathological changes in human tissues, the biochemical mechanisms of these changes have yet to be determined. In hypophosphataemia, it has been suggested that orthophosphate (Pi) diffuses out of cells down its concentration gradient, leading to depletion of intracellular Pi and impairment of cellular energy metabolism [4] . An understanding of the factors controlling the distribution of Pi between cells and extracellular fluid is therefore an important prerequisite in studying these disorders.
Early work on human erythrocytes indicated that the distribution of Pi across the cell membrane was determined by passive diffusion, so that changes in cellular Pi concentration were directly proportional to those in plasma [5]. However, in patients with Paget's disease of bone who were made hyperphosphataemic by treatment with the drug ethylidene-l-hydroxy-1,l-bisphosphonate (EHBP), the increase in cellular Pi concentration in the erythrocytes, blood platelets and leucocytes of treated patients was small in comparison with that in plasma [6] . Similarly, in the skeletal muscle of mildly hypophosphataemic patients with vitamin D-resistant rickets (VDRR), measurements using the non-invasive technique of 31P nuclear magnetic resonance (31P n.m.r.) [7] suggested that the sarcoplasmic Pi concentration was similar to that in the muscle of healthy controls [8] . It seemed likely therefore that passive distribution of Pi across the plasma membrane was not the only factor determining the cellular concentration of Pi.
In this paper, we describe a more detailed study of this problem. The study had three main aims. Firstly, we have measured the Pi concentration in erythrocytes as a function of plasma Pi in patients with Paget's disease before and after treatment with EHBP, and in patients with VDRR. Measurements were made in cells chilled on ice under air, and samples incubated at 37°C under a 5% CO, atmosphere, to determine whether our earlier observations could have been influenced by the use of chilled samples [6, 91. Secondly we have measured changes in erythrocyte Pi concentrations in cells from healthy controls, in which plasma Pi concentration was raised by addition of Pi in vitro, in order to eliminate the effects of clinical variables such as disease and drug therapy. Thirdly, we have used 31P n.m.r. to estimate changes in Pi concentration in skeletal muscle of patients with these disorders, in order to complement the earlier observations [6], with a completely different tissue and a non-invasive technique. A preliminary account of this work has been presented [lo] .
Methods

Subjects
Measurements were performed on patients with Paget's disease of bone, before and during oral treatment with the drug EHBP (disodium salt), 1600 mg (6.4 mmol)/day [ l l , 121. At this dose, the drug stimulates active renal tubular reabsorption of Pi, which leads to a progressive increase in plasma Pi concentration over the first 2 weeks of treatment [ 131. The concentration then stabilizes provided that treatment continues [ 131. Measurements were made immediately before, and 2 weeks after, treatment had started.
Patients with VDRR (inherited infantile-onset hypophosphataemia) [ 141 were studied to provide a hypophosphataemic comparison with the patients with Paget's disease. None of the patients had received oral Pi or vitamin D supplements for at least 1 week before the study, and none showed any sign of myopathy at the time of the measurements.
Details of patients' age and sex are given in figure legends and Table 1 .
All patients gave informed consent, which had the prior approval of the local Ethical Committee.
31P n m r . measurements in muscle
Measurements of intramuscular phosphorus metabolites were made on the patient's flexor digitorum superficialis muscle, by procedures described in detail elsewhere [7] . Briefly, spectra were obtained on a TMR-32 Fourier transform spectrometer (Oxford Research Systems), interfaced with a 1.89T superconducting magnet with a 20 cm bore (Oxford Instruments). Each Cells were incubated in autologous plasma at 10-15% PCV. At t = 0 , 1.3 pmol of Na,HPO, was added per ml of 'test' suspension, and 2.6 pmol of NaCl per ml of 'control'. Each suspension was sampled in triplicate after 90 or 180 min, and the mean of the two samples was calculated. Values are means (SD) for six normal volunteers (four male, two female; age 21-28 years), and were determined by direct assay of Pi ('observed') or by calculation [ 51 from the cell/plasma distribution of chloride ('predicted'). *P < 0.02 relative to corresponding observed value; **P< 0.001 relative to corresponding control ratio.
Concn.
Concn patient's arm was inserted in the bore of the magnet, with a 2.5 cm surface coil positioned over the finger flexors. Radiofrequency pulses were applied at 2 s intervals, using a flip angle of approximately 70", measured on axis in the plane of the coil. After spectra of resting muscle had been recorded, the patient exercised the muscles by squeezing the rubber bulb of a sphygmomanometer to 100 mmHg (13.3 kPa) 22 times per min for 5 min, and then to 300 mmHg (39.9 kPa) for a further 2 min. Changes in the spectra were monitored during this exercise, and for 12 min after it had ceased. The concentrations of sarcoplasmic phosphoruscontaining metabolites were derived from the 31P n.m.r. spectra as previously described [7, 151. After correction for magnetic saturation [7] the peak areas are proportional to the concentrations of freely mobile metabolites (i.e. those dissolved in the intracellular water). To estimate absolute concentrations, the B-ATP was used as the internal standard, assuming a concentration in resting muscle of 5.5 mmol/kg wet wt. [16, 17] and anintracellular water content of 0.67 cm3/g wet wt. of muscle [18] . Concentrations of Pi and phosphocreatine were then calculated from the peak area ratios. In view of the high ratio of cellular to extracellular volume in muscle [ 181, the contribution of extracellular Pi to the Pi peak is negligible, even in hyperphosphataemic patients. A small contribution from mitochondria1 Pi has been reported in rat heart [19] , but none would be expected in skeletal muscle because of the low mitochondrial volume of this tissue.
Intracellular pH was determined from the chemical shift difference between the Pi and phosphocreatine peaks as previously described [7] .
Chemical Pi measurements in erythrocytes
Heparinized samples (10 ml) of venous blood were drawn and immediately placed on ice to minimize changes in blood gas composition. The sample was split into two portions. One was centrifuged at 1000 g,,, for 5 min at 4"C, and immediately placed back on ice. Sufficient plasma was removed to leave a suspension of approximately 60% packed cell volume (PCV) and, 30 min after the sample was drawn from the donor, aliquots of this chilled suspension and plasma were deproteinized as described below. The other portion was incubated in autologous plasma at 10-15% PCV under watersaturated O,+CO, (95:5, v/v) in a water bath at 37°C. After 90 or 180 min at 37"C, the cells were allowed to sediment under gravity to 50% PCV, and aliquots of suspension or plasma were drawn (still under O,+CO,, 95:5, at 37°C) and immediately deproteinized. Preliminary experiments indicated that, even when an extracellular Pi load was added, the cell/plasma Pi distribution re-established a steady state in about 60 min at 37°C. All 37°C results presented here are the means of 90 and 180 min values.
Samples were assayed for Pi with the colorimetric procedure described previously [9] , but the volumes of reagents were modified as follows in order to improve recovery of Pi. Samples of cell suspension or plasma (25 pl) were deproteinized with 0.73 mol/l perchloric acid (275 pl) and, after centrifugation to remove protein, the supernatant was neutralized with 4.3 mol/l potassium hydroxide containing 0.6 mol/l imidazole, A wide-range pH indicator (BDH 21072) was added to give a final concentration of 2% (v/v). An aliquot of this neutralized extract (100 pl) was mixed with 400 p1 of water and 250 pl of acidified molybdate reagent 
In practice, for erythrocyte experiments, we have measured molar concentrations (moles per litre of packed cells or plasma) throughout this paper. If erythrocytes are assumed to contain 0.72 kg of water/l of packed cells [20] Chloride was measured as described in [22] .
by Student's t-analysis.
Statistical significance of changes was assessed
Results
Erythrocyte Pi in patients
The concentration of Pi in the erythrocytes of the patients and normal volunteers has been plotted as a function of the concentration of Pi in their blood plasma in Fig. 1( a) . If the cellular concentration of Pi is controlled solely by passive distribution of Pi across the cell membrane, a linear regression through these data should pass through the origin [5] . In practice, a significant non-zero intercept is obtained by extrapolation on the ordinate ( P < 0.001). Consequently, even though plasma Pi spans a tenfold range of concentration (0.2-2.0 mmol/l), the corresponding concentrations of Pi in the cells at steady state increase only two-to threefold. A more detailed comparison of the observed values with the results predicted from the passive distribution model (see the Methods section) is presented in Fig. 1(b) and l(c) . The linear regression through the observed cell/plasma concentration ratios (Fig. lb) has a significant negative slope ( P < 0.02), whereas the slope of the regression through the values predicted from the cell/plasma distribution of chloride (Fig. lc) is close to zero, and is significantly less than the slope in Fig. l(b) ( P < 0.01). for ( b ) but the ratios were predicted from the passive distribution model, using the calculation for Rpred described in the Methods section. Extrapolated intercept in ( a ) differs significantly from zero ( P < 0.001). Slope in (b) differs significantly from that in (c) ( P < 0.01).
Effect of chilling under air
In erythrocytes from the 16 patients in Fig. 1( a) , cell Pi was also measured in freshly drawn blood stored for 30 min on ice under air. (This is the procedure that was used in earlier studies on erythrocyte Pi [6. 91.) A linear regression through the data from these patients' cells at 37°C is close to that shown in Fig. l ( a ) , with a slope of 0.22 (SE 0.04), whereas, in the blood chilled under air, the slope is 64% higher [0.36 (SE 0.03), P < 0.011. There is no significant change in the intercept on the ordinate.
Manipulation ofplasma Pi in vitro
In order to eliminate clinical variables, the concentration of Pi in plasma was raised in vitro, in blood from healthy volunteers, by addition of Na,HPO,. When the Pi had attained a new steadystate distribution between the erythrocytes and plasma, the corresponding increase in erythrocyte Pi was again found to be small in comparison with that in plasma, leading to a decrease in the cell/ plasma concentration ratio for Pi (Table 1) . As in Fig. 1( c) , values for the cell/plasma concentration ratio for Pi, which were calculated from the cell/ plasma concentration ratio for chloride in accordance with the passive distribution model, showed no dependence on plasma Pi (Table 1) .
3LP n.m.r. measurements in muscle
Intramuscular concentrations of Pi have been piotted as a function of the corresponding concentrations in the plasma of these patients in Fig. 2 . A linear regression through these data, extrapolated on to the ordinate, yields a siqficant non-zero intercept ( P < 0.00 1) so that, as for the erythrocytes in Fig. l(a) , the intracellular concentration of Pi does not increase in direct proportion to that in plasma.
In addition the intramuscular pH and the relative concentrations of Pi, phosphocreatine and ATP were monitored at rest, during exercise (see the Methods section) and during recovery from exercise. However, in all groups of patients, none of these parameters showed any significant deviation from the values observed in normal subjects [15] .
Discussion
The plasma membranes of human erythrocytes [9, 231 and skeletal myocytes [24] are sufficiently permeable to Pi to allow detectable bulk movement of Pi across the membranes on a time-scale of minutes. Therefore, the main observation in this paper, that the cytoplasmic concentration of Pi in these cells at steady state does not change in direct proportion to the plasma concentration of Pi, implies that these cells have some ability to buffer or regulate the concentration of Pi in their cytoplasm. These results are consistent with the disproportionately small changes in Pi concentration observed by chemical assays in the skeletal muscle of hypophosphataemic dogs [25] , and in the erythrocytes, blood platelets and leucocytes of hyperphosphataemic patients receiving EHBP [6] .
In contrast, the concentration of extractable Pi in erythrocytes of patients with more extreme plasma concentrations of Pi [9] , or in the myocardium [26] and skeletal muscle [27] of severely phosphorusdeprived rats, has been reported to change in direct proportion to the extracellular Pi concentration. However, a non-linear relationship between cellular and extracellular Pi could also be consistent with these data [9, 26, 271, which implies that these cells can only control their cytoplasmic concentration of Pi over a limited range of plasma Pi Concentrations.
The conclusions drawn from the patients' n.m.r. data in Fig. 2 are valid only if the concentration of ATP in the muscle did not vary as a function of the plasma concentration of Pi (see the Methods section). Chemical measurements in resting skeletal muscle of phosphorus-deprived animals indicate that ATP concentrations are not affected by changes in extracellular Pi [4, 25, 271, even when intramuscular Pi is depleted. It is therefore unlikely that the degree of hypo-and hyper-phosphataemia in Fig. 2 had any systematic effect on intramuscular ATP, and this is confirmed by the fact that none of the patients showed any myopathy, or abnormal changes in their 31P n.m.r. spectra during exercise.
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Earlier observations of unexpectedly small changes in cellular Pi in erythrocytes during hyperphosphataemia [6] were made on patients' cells which had been chilled on ice while they were transported to the laboratory. However, a similar result was still obtained in the present study at 37°C (Fig.  1) ; and paired 0°C and 37°C measurements indicated that, far from being an artifact of chilling, this effect could have been significantly underestimated at 0°C under air. This is probably more than an effect of temperature, as blood gas composition, and hence pH, may vary slightly during the incubations on ice.
In examining the cell/plasma Pi distribution in the erythrocytes and muscle of these patients, we have assumed that VDRR, Paget's disease and EHBP have not directly affected the cell/plasma Pi distribution. In VDRR, there is thought to be a defect in renal and intestinal Pi transport [14] , which could conceivably extend to erythrocytes [5] and muscle. If ahything, this should lead to an anomalously low cytoplasmic concentration of Pi, which is the opposite of what is observed in Fig. 1 and Fig. 2 . In addition, two lines of evidence suggest that Paget's disease and EHBP have no marked effects on phosphate metabolism in these cells. Firstly, in muscle, all of the parameters measured by n.m.r. at rest and during recovery after exercise, were similar to the values in normal subjects. Secondly, in normal erythrocytes incubated with added Pi in vitro (Table l) , the changes in cellular Pi concentration were consistent with those seen in the patients' cells at 37°C. It remains to be shown that this effect in vitro persists for days or weeks, as in the patients, but the results imply that this is the normal response of erythrocytes to hyperphosphataemia.
In erythrocytes, comparison of measured cell/ plasma concentration ratios for Pi ( Fig. 16 and Table 1 ) with the ratios predicted from the passive distribution model (Fig. l c and Table 1 ) shows that the cell maintains an unexpectedly high cytoplasmic concentration of Pi as plasma Pi decreases. The horizontal trend in Fig. l(c) also shows that the effect in Fig. l(b) is not a non-specific change in anion distribution arising from altered membrane potential, pH or cell water content. However, the discrepancy between Fig. l(b) and l(c) cannot be attributed to active transport of Pi into the cells until other factors such as intracellular binding of Pi, or generation of Pi from organic phosphates during the incubations, have been excluded.
In muscle, on the other hand, it is difficult to avoid the conclusion that sarcoplasmic Pi is maintained by active transport. If the membrane potential is taken to be -82 mV [28] , extracellular pH is 7.4 and extracellular Pi is 1 rnmol/l of water, the sarcoplasmic Pi concentration predicted from the passive distribution model [ 5 ] is only 0.01 mmol of Pill of cell water; whereas, as shown in Fig. 2 , the observed value is 4 mmol/l of cell water. The data in Fig. 2 imply that this putative transporter adjusts its activity to regulate cellular Pi in the face of changes in extracellular Pi, so it will now be interesting to see whether this mechanism is related to that used by renal tubular epithelium to regulate the concentration of Pi in extracellular fluid [29] .
